Hormone Receptor Positive Tumor

Also known as: Hormone receptor positive tumor (disorder)

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB06643	Denosumab	0	Active Not Recruiting	1
DB12001	Abemaciclib	1	Active Not Recruiting	1
DB00947	Fulvestrant	1	Active Not Recruiting	1
DB09073	Palbociclib	1	Active Not Recruiting	1
DB11730	Ribociclib	1	Active Not Recruiting	1
DB11760	Talazoparib	1	Completed	1
DB16412	Adebrelimab	1 / 2	Recruiting	1
DB01217	Anastrozole	1 / 2	Active Not Recruiting	1
DB14776	Camrelizumab	1 / 2	Recruiting	1
DB00958	Carboplatin	1 / 2	Recruiting	1
DB00531	Cyclophosphamide	1 / 2	Recruiting	1
DB17456	Dalpiciclib	1 / 2	Recruiting	1
DB00445	Epirubicin	1 / 2	Recruiting	1
DB15637	Fluzoparib	1 / 2	Recruiting	1
DB00014	Goserelin	1 / 2	Recruiting	1
DB01006	Letrozole	1 / 2	Recruiting	1
DB01229	Paclitaxel	1 / 2	Recruiting	1
DB06366	Pertuzumab	1 / 2	Recruiting	1
DB14993	Pyrotinib	1 / 2	Recruiting	1
DB00072	Trastuzumab	1 / 2	Recruiting	1
DB11925	Vistusertib	1 / 2	Active Not Recruiting	1
DB12001	Abemaciclib	2	Active Not Recruiting	1
DB12001	Abemaciclib	2	Completed	1
DB12001	Abemaciclib	2	Recruiting	1
DB01217	Anastrozole	2	Active Not Recruiting	1
DB01217	Anastrozole	2	Completed	2
DB01217	Anastrozole	2	Not Yet Recruiting	2
DB01217	Anastrozole	2	Terminated	1
DB18290	Anvatabart opadotin	2	Recruiting	1
DB14776	Camrelizumab	2	Recruiting	1
DB14707	Cemiplimab	2	Recruiting	1
DB00531	Cyclophosphamide	2	Completed	1
DB17456	Dalpiciclib	2	Recruiting	1
DB16410	Datopotamab deruxtecan	2	Recruiting	1
DB15627	Dostarlimab	2	Recruiting	1
DB00997	Doxorubicin	2	Completed	1
DB00997	Doxorubicin	2	Recruiting	1
DB11714	Durvalumab	2	Recruiting	1
DB11714	Durvalumab	2	Terminated	1
DB06374	Elacestrant	2	Recruiting	1
DB01590	Everolimus	2	Completed	1
DB01590	Everolimus	2	Recruiting	1
DB00990	Exemestane	2	Active Not Recruiting	1
DB00990	Exemestane	2	Completed	1
DB00990	Exemestane	2	Not Yet Recruiting	2
DB00990	Exemestane	2	Terminated	1
DB11741	Famitinib	2	Recruiting	1
DB15637	Fluzoparib	2	Recruiting	1
DB00947	Fulvestrant	2	Active Not Recruiting	1
DB00947	Fulvestrant	2	Completed	2
DB00947	Fulvestrant	2	Recruiting	1
DB12047	Ganetespib	2	Recruiting	1
DB12205	Ganitumab	2	Recruiting	1
DB00014	Goserelin	2	Active Not Recruiting	1
DB00014	Goserelin	2	Recruiting	1
DB06186	Ipilimumab	2	Completed	1
DB00762	Irinotecan	2	Recruiting	1
DB15409	Ladiratuzumab vedotin	2	Recruiting	1
DB06202	Lasofoxifene	2	Recruiting	1
DB01006	Letrozole	2	Active Not Recruiting	1
DB01006	Letrozole	2	Completed	2
DB01006	Letrozole	2	Not Yet Recruiting	2
DB01006	Letrozole	2	Recruiting	2
DB01006	Letrozole	2	Terminated	1
DB00836	Loperamide	2	Completed	1
DB14123	Menthol	2	Recruiting	1
DB00331	Metformin	2	Recruiting	1
DB11828	Neratinib	2	Recruiting	1
DB09035	Nivolumab	2	Completed	1
DB09074	Olaparib	2	Recruiting	1
DB14954	PIK3CA	2	Recruiting	1
DB01229	Paclitaxel	2	Recruiting	1
DB09073	Palbociclib	2	Active Not Recruiting	1
DB09073	Palbociclib	2	Completed	2
DB12090	Patritumab	2	Recruiting	1
DB09037	Pembrolizumab	2	Recruiting	1
DB06366	Pertuzumab	2	Recruiting	1
DB12978	Pexidartinib	2	Recruiting	1
DB00396	Progesterone	2	Recruiting	1
DB14993	Pyrotinib	2	Not Yet Recruiting	2
DB11760	Talazoparib	2	Recruiting	1
DB00675	Tamoxifen	2	Active Not Recruiting	2
DB00675	Tamoxifen	2	Recruiting	1
DB00072	Trastuzumab	2	Not Yet Recruiting	2
DB00072	Trastuzumab	2	Recruiting	1
DB16342	Trastuzumab duocarmazine	2	Recruiting	1
DB05773	Trastuzumab emtansine	2	Recruiting	1
DB12056	Trebananib	2	Recruiting	1
DB15442	Trilaciclib	2	Recruiting	1
DB06825	Triptorelin	2	Recruiting	1
DB11652	Tucatinib	2	Recruiting	1
DB07232	Veliparib	2	Recruiting	1
DB15471	Zanidatamab	2	Recruiting	1
DB00112	Bevacizumab	3	Completed	1
DB01101	Capecitabine	3	Completed	1
DB01590	Everolimus	3	Unknown Status	1
DB00990	Exemestane	3	Unknown Status	1
DB00947	Fulvestrant	3	Completed	1
DB00947	Fulvestrant	3	Unknown Status	1
DB01229	Paclitaxel	3	Completed	1
DB11730	Ribociclib	3	Completed	1